Advertisement

Topics

Innophos Holdings, Inc. Company Profile

11:20 EDT 19th September 2017 | BioPortfolio


News Articles [460 Associated News Articles listed on BioPortfolio]

Innophos To Present At Jefferies 2017 Industrials Conference

CRANBURY, N.J., Aug. 2, 2017 /PRNewswire/ -- Innophos Holdings, Inc. (NASDAQ: IPHS), today announced that Han Kieftenbeld, Senior Vice President and Chief Financial Officer, will address the Jeff...

Innophos To Host Second Quarter 2017 Financial Results Conference Call On August 1

CRANBURY, N.J., July 19, 2017 /PRNewswire/ -- Innophos Holdings, Inc. (Nasdaq: IPHS), a leading international producer of performance-critical and nutritional specialty ingredients and custom-for...

Innophos Holdings, Inc. To Host Second Quarter 2017 Financial Results Conference Call On August 1

  Life Sciences Jobs   ...

Innophos Holdings, Inc. Completes Acquisition Of Creating A Nearly $0.5 Billion Food, Health And Nutrition Platform

  Life Sciences Jobs   ...

GenNx360 Capital Partners Announces Closing On Sale Of Its Portfolio Company Novel Ingredients To Innophos Holdings, Inc.

  Life Sciences Jobs   ...

Innophos Holdings, Inc. Announces Acquisition of Triarco Industries for $46 Million

CRANBURY, N.J., Jan. 2, 2013 /PRNewswire/ -- Innophos Holdings, Inc. (NASDAQ: ''IPHS"), a leading international producer of performance-critical and nutritional specialty ingredients, with...

Innophos Holdings, Inc. Releases 2016 Quarterly Results Reflecting Previously Announced New Operating Segments

CRANBURY, N.J., May 16, 2017 /PRNewswire/ -- Innophos Holdings, Inc. (NASDAQ: IPHS), today publicized its 2016 quarterly segment results according to the new operating segments that were implemen...

GenNx360 Capital Partners Announces Closing on Sale of Its Portfolio Company Novel Ingredients to Innophos Holdings, Inc.

NEW YORK, Aug. 31, 2017 /PRNewswire/ -- GenNx360 Capital Partners ("GenNx360"), a New York-based private equity firm focused on acquiring middle market industrial and business services companies,...

PubMed Articles [8 Associated PubMed Articles listed on BioPortfolio]

Case-control study on the use of pituitary-derived hormones from sheep as a potential risk factor for the occurrence of atypical scrapie in Great Britain.

A case-control study was conducted in 2013 to investigate the use of pituitary-derived hormones from sheep as a potential risk factor for the presence of atypical scrapie in Great Britain sheep holdin...

The Sharing Experimental Animal Resources, Coordinating Holdings (SEARCH) Framework: Encouraging Reduction, Replacement, and Refinement in Animal Research.

While significant medical breakthroughs have been achieved through using animal models, our experience shows that often there is surplus material remaining that is frequently never revisited but could...

Modelling virus coinfection to inform management of maize lethal necrosis in Kenya.

Maize lethal necrosis (MLN) has emerged as a serious threat to food security in sub-Saharan Africa. MLN is caused by coinfection with two viruses, maize chlorotic mottle virus (MCMV) and a potyvirus, ...

Impact of genetic variation on three dimensional structure and function of proteins.

The Protein Data Bank (PDB; http://wwpdb.org) was established in 1971 as the first open access digital data resource in biology with seven protein structures as its initial holdings. The global PDB ar...

Antibiotic drug usage in pigs in Germany-Are the class profiles changing?

The development of antimicrobial resistance is triggered by the use of antibiotic drugs. Therefore, the consumption of antibiotics in livestock is monitored, and different measures may be applied if t...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Study of Pharmacokinetics and Preliminary Efficacy in Patients With Niemann-Pick C1

This research study is being conducted to find out whether Trappsol® Cyclo™, an experimental treatment for people with Niemann-Pick disease Type C1 (NPC-1) is safe at 3 different dose l...

Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 (NPC1)

This research study is being conducted to find out whether Trappsol® Cyclo™, an experimental treatment for people with Niemann Pick disease Type C (NPC-1) is safe at 2 different dose le...

Companies [411 Associated Companies listed on BioPortfolio]

Innophos Holdings, Inc.

Integra Holdings

Founded by Yissum, Integra Holdings is a unique venture fund, focusing on an exclusive selection of biotech companies with proprietary solutions and a competitive advantage in the...

Sabre Holdings

Sabre Holdings connects people with the world's greatest travel possibilities by retailing travel products and providing distribution and technology solutions for the travel indus...

HealthTech Holdings, Inc.

HealthTech Holdings, Inc. is a health information technology holding-company, with portfolio companies including HMS, MEDHOST and Sentry Healthcare Services, Inc. HealthTec...

HealthTech Holdings Inc.

HealthTech Holdings Inc. is a health information technology holding company that owns Healthcare Management Systems, MEDHOST and Sentry Healthcare Services. HealthTe...

More Information about "Innophos Holdings, Inc." on BioPortfolio

We have published hundreds of Innophos Holdings, Inc. news stories on BioPortfolio along with dozens of Innophos Holdings, Inc. Clinical Trials and PubMed Articles about Innophos Holdings, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Innophos Holdings, Inc. Companies in our database. You can also find out about relevant Innophos Holdings, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record